7 digital health ‘unicorn’ exits in 2020

With digital health adoption rates skyrocketing from the COVID-19 pandemic, healthcare ‘unicorn’ activity hit record levels in 2020, according to a recent CB Insights report.

Advertisement

The digital health space saw seven ‘unicorn’ companies, or private companies valued at more than $1 billion, exit. The exit activity, which is when the company goes public or is acquired, nearly doubled the four exits in 2019 and two exits in 2018.

Here are the seven digital health unicorns that exited in 2020 as well as their valuations:

  • GoodRx: $12.7 billion
  • Grail: $8 billion
  • Gan & Lee: $3.6 billion
  • Cure Vac: $2.8 billion
  • One Medical: $1.7 billion
  • Hims & Hers $1.6 billion
  • Butterfly: $1.5 billion

More articles on digital transformation:
Online symptom checkers can lead to delayed treatment for serious conditions: study
Apple, Harvard team up on menstrual symptom study
Fast Company’s 10 most innovative health tech companies of 2021

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Scaling, Stopping, and Measuring AI Value — Why Your Approach Matters More Than Your Next Pilot

Monday, July 27
1:00 PM - 2:00 PM CDT

Presenters: Kay Burke, UCSF HealthNagesh Badarla, HuronAlene Cuellar, Huron

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.